Fig. 5From: Modelling the cost-effectiveness of pay-for-performance in primary care in the UKCost-effectiveness ratio (£/QALY) for the QOF versus non-QOF as a function of non-fatal-to-fatal CVD events averted. CVD cardiovascular disease, ICER incremental cost-effectiveness ratio, QALY quality-adjusted life year, QOF Quality and Outcomes FrameworkBack to article page